The VIVEVE TREATMENT uses a patented, cryogen-cooled radiofrequency device that rebuilds natural collagen to improve the structural integrity of the vagina and to support the urethra. The Viveve treatment was previously called the “Geneveve” treatment and is a non surgical option to treat women who are experiencing urinary incontinence – leaking urine when laughing, coughing, sneezing, or jumping; sexual dysfunction and vaginal laxity – the stretching and expansion of vaginal tissue after childbirth, with age or due to hormonal changes.
SINGLE TREATMENT; NO DOWNTIME!
The Viveve System is a patented, cryogen-cooled monopolar, radiofrequency (CMRF) energy delivery system. Controlled-cooling protects the vaginal mucosal surface from damage and impacts the resistance of the epithelial layer which allows for greater penetration of the RF energy. RF consistently and safely delivers 90J/cm2 of energy deep into the lamina propria up to the muscularis, where the energy is safely dispersed without any effect on paravaginal tissues and organs.
The Viveve Treatment works via a small probe that’s inserted into the vagina, which emits cryogen cooling to protect the tissue and radiofrequency waves to heat the tissue. This prompts the production of new collagen, and allows the vagina to regain its prior structure and function. In turn, laxity is decreased and sensation is restored.
Viveve is an approved treatment for stress urinary incontinence, vaginal laxity, and improved female sexual function throughout the world. In the US, Viveve is used off label for these same indications as the company is currently going through the regulatory process to get approval for treating stress urinary incontinence, vaginal laxity, and improved female sexual response.
Viveve is the first company in the women’s intimate health space to have completed a randomized, blinded placebo-controlled study.
Positive patient outcomes have been reported in a study following ONE treatment for sexual function and vaginal laxity. Results were sustained at least 12 months. Ongoing studies have shown 69% of stress urinary incontinence (SUI) patients achieve a ≥50% reduction in 1-hour pad weight at 6 months. The average reduction from baseline in 1-hour pad weight overall was 73% and the results were sustained at least 12 months.
The Viveve treatment uses a patented medical device that utilizes cryogen cooling on the superficial layers and radiofrequency heating in the deeper layers to induce a person’s body to produce collagen in the treatment areas.
The Viveve treatment offers a non surgical alternative for stress urinary incontinence (urine leakage with aughing, coughing, sneezing, jumping, running and other exercise). Viveve can also treat female sexual dysfunction as a result of vaginal laxity, lack of sensitivity, and painful intercourse.
Any woman whose life is controlled by urinary leakage issues requiring daily pad use can benefit from the Viveve treatment. Additionally, women who do not have a fulfilling sexual life because of vaginal laxity, lack of sensitivity, and painful intercourse can also benefit from the Viveve treatment.
Unlike other female intimate rejuvenation/restoration treatments, clinical studies show the benefits of the Viveve treatment to last well beyond a year. As the aging process continue, some women may need a maintenance treatment in the future.
The medical device cools the surface layers simultaneously while heating the deeper layers and patients normally only feel warm and cool sensations without any pain. No systemic or topical anesthetic is necessary.
The Viveve Treatment is a single in office procedure that normally takes 45-60 minutes.
The Vveve Treatment is a ‘no downtime” procedure with most patients resuming all physical activities as tolerated.
The national averages for the Viveve treatment ranges from $3000-$4000. The Viveve Treatment is an individualized treatment specific for each patient and the cost is dependent on individual factors. At ReGenWoman Medical Group, we tailor the treatment and the pricing towards the needs of each individual woman and we have various discounted options and no interest financing available, both presented at the time of the consultation.